GILEAD SCIENCES, INC. — Director's Dealing 2018

Mar 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-03-09

Reporting Person: MARTIN JOHN C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-09	Non-qualified Stock Option (Right to Buy)	$80.72	A	1309	Acquired	2028-03-09	Common Stock (1309)	Direct
2018-03-09	Restricted Stock Unit	$	A	310	Acquired		Common Stock (310)	Direct

Footnotes

F1: Options vest quarterly over the first year of service.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: 100% of the restricted stock units will vest in one year on the anniversary date of the grant.